STENT UP

Over 150 million people worldwide are affected by a cerebral aneurysm. To prevent aneurysm rupture, various implants are used for treatment, but they face a major issue: a lack of long-term stability, leading to the need for retreatment in 1 out of 10 cases within a year.

Stent Up is developing NenU, the new technology of aneurysm implant to avoid retreatments and improve life expectancy.

Our commitment is to increase the number of patient survival and improve their stroke treatment.

We design, develop and market innovative solutions and medical devices. Patients will therefore be able to benefit from better conditions during their stroke treatment.